Search research articles
Contact Us
Filters
Showing results (321-330 of 580) with videos related to
Page
of 58
Sort By:
Frontiers in Oncology
|
August 17, 2019
Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
Akshita B Bhatt, Mohit Gupta, Van T Hoang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2016
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
Kensuke Tateishi, A John Iafrate, Quan Ho, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2016
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms
M R Trusheim, A A Shrier, Z Antonijevic, et al.
Plos One
|
March 26, 2013
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling
Brijal M Desai, Jessie Villanueva, Thierry-Thien K Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2010
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Anne M Traynor, Maureen Hewitt, Glenn Liu, et al.
Cancer
|
June 8, 2012
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy
Daniel C Cho, Thomas E Hutson, Wolfram Samlowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Victoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Cancer Research
|
January 11, 2007
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells
Keiran S M Smalley, Rooha Contractor, Nikolas K Haass, et al.
Journal of Virology
|
August 1, 1997
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence
J L Mankowski, M T Flaherty, J P Spelman, et al.
Cancer Discovery
|
September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα
Michael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Page
of 58
Search research articles
Search
Showing results (321-330 of 580) with videos related to
Sort By:
Page
of 58
Frontiers in Oncology
|
August 17, 2019
Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
Akshita B Bhatt, Mohit Gupta, Van T Hoang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2016
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
Kensuke Tateishi, A John Iafrate, Quan Ho, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2016
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms
M R Trusheim, A A Shrier, Z Antonijevic, et al.
Plos One
|
March 26, 2013
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling
Brijal M Desai, Jessie Villanueva, Thierry-Thien K Nguyen, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2010
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Anne M Traynor, Maureen Hewitt, Glenn Liu, et al.
Cancer
|
June 8, 2012
Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy
Daniel C Cho, Thomas E Hutson, Wolfram Samlowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Victoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Cancer Research
|
January 11, 2007
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells
Keiran S M Smalley, Rooha Contractor, Nikolas K Haass, et al.
Journal of Virology
|
August 1, 1997
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence
J L Mankowski, M T Flaherty, J P Spelman, et al.
Cancer Discovery
|
September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα
Michael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Page
of 58